For biotech educational purposes! Came across this graph of CVTX. It charts the ratching up of Ranexa sales for CVTX vs their PPS price over about 2 years. It also adds in the significant news events that have occurred for CVTX during the time period. These events include data presentation to the public as they become available across the sales axis, FDA approvals, partnerships, and milestone payments off those partnerships.
This PPS activity versus the good stuff happening at this company is exactly what is wrong with biotech investing today! Not only do you have to negotiate the intrinsic toughness of anticipating and doing due diligence on these PR timepoints, you now have to evaluate the capability of hedgefunds to short these stocks with their power, the fallout when hedgefunds explode and redemptions come due, the credit crunch, economic maliase, and the FDA!
A similar chart can be drawn for BMRN pr PGNX! CVTX and PGNX should be at $20.00-25.00 and BMRN should be at least $40.00 using metrics from 5 years ago. They are not! good fundamental and technical analysis does not assure profit when playing these anymore. The marketplace itself has taken a tough markket space to play and turned it into a joke! Good is bad-bad s good-sometimes it just doesn't matter! This is what we get for polluting our marketplace with all we have seen eminating from it for several years
Thats alot of shit to negotiate and a shithole for retailers to play for profit!
Kutz 
Free Forum Hosting
Important Announcement
Prev Message
New Discussion
Recommend